641 related articles for article (PubMed ID: 19782055)
1. Dynorphin, stress, and depression.
Knoll AT; Carlezon WA
Brain Res; 2010 Feb; 1314():56-73. PubMed ID: 19782055
[TBL] [Abstract][Full Text] [Related]
2. Kappa-Opioid Antagonists for Psychiatric Disorders: From Bench to Clinical Trials.
Carlezon WA; Krystal AD
Depress Anxiety; 2016 Oct; 33(10):895-906. PubMed ID: 27699938
[TBL] [Abstract][Full Text] [Related]
3. The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors.
Bruchas MR; Land BB; Chavkin C
Brain Res; 2010 Feb; 1314():44-55. PubMed ID: 19716811
[TBL] [Abstract][Full Text] [Related]
4. Kappa opioid receptor signaling in the basolateral amygdala regulates conditioned fear and anxiety in rats.
Knoll AT; Muschamp JW; Daws SE; Ferguson D; Dietz DM; Meloni EG; Carroll FI; Nestler EJ; Konradi C; Carlezon WA
Biol Psychiatry; 2011 Sep; 70(5):425-33. PubMed ID: 21531393
[TBL] [Abstract][Full Text] [Related]
5. Role of kappa-opioid receptors in stress and anxiety-related behavior.
Van't Veer A; Carlezon WA
Psychopharmacology (Berl); 2013 Oct; 229(3):435-52. PubMed ID: 23836029
[TBL] [Abstract][Full Text] [Related]
6. Stress produces aversion and potentiates cocaine reward by releasing endogenous dynorphins in the ventral striatum to locally stimulate serotonin reuptake.
Schindler AG; Messinger DI; Smith JS; Shankar H; Gustin RM; Schattauer SS; Lemos JC; Chavkin NW; Hagan CE; Neumaier JF; Chavkin C
J Neurosci; 2012 Dec; 32(49):17582-96. PubMed ID: 23223282
[TBL] [Abstract][Full Text] [Related]
7. The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system.
Land BB; Bruchas MR; Lemos JC; Xu M; Melief EJ; Chavkin C
J Neurosci; 2008 Jan; 28(2):407-14. PubMed ID: 18184783
[TBL] [Abstract][Full Text] [Related]
8. Role of the Dynorphin/Kappa Opioid Receptor System in the Motivational Effects of Ethanol.
Anderson RI; Becker HC
Alcohol Clin Exp Res; 2017 Aug; 41(8):1402-1418. PubMed ID: 28425121
[TBL] [Abstract][Full Text] [Related]
9. Stress-Induced Reinstatement of Nicotine Preference Requires Dynorphin/Kappa Opioid Activity in the Basolateral Amygdala.
Nygard SK; Hourguettes NJ; Sobczak GG; Carlezon WA; Bruchas MR
J Neurosci; 2016 Sep; 36(38):9937-48. PubMed ID: 27656031
[TBL] [Abstract][Full Text] [Related]
10. Kappa Opioid Receptors in the Pathology and Treatment of Major Depressive Disorder.
Browne CA; Wulf H; Lucki I
Handb Exp Pharmacol; 2022; 271():493-524. PubMed ID: 33580854
[TBL] [Abstract][Full Text] [Related]
11. Effects of acute and chronic social defeat stress are differentially mediated by the dynorphin/kappa-opioid receptor system.
Donahue RJ; Landino SM; Golden SA; Carroll FI; Russo SJ; Carlezon WA
Behav Pharmacol; 2015 Oct; 26(7 Spec No):654-63. PubMed ID: 26110224
[TBL] [Abstract][Full Text] [Related]
12. The kappa opioid receptor antagonist aticaprant reverses behavioral effects from unpredictable chronic mild stress in male mice.
Jacobson ML; Wulf HA; Browne CA; Lucki I
Psychopharmacology (Berl); 2020 Dec; 237(12):3715-3728. PubMed ID: 32894343
[TBL] [Abstract][Full Text] [Related]
13. Dynorphin/Kappa Opioid Receptor Signaling in Preclinical Models of Alcohol, Drug, and Food Addiction.
Karkhanis A; Holleran KM; Jones SR
Int Rev Neurobiol; 2017; 136():53-88. PubMed ID: 29056156
[TBL] [Abstract][Full Text] [Related]
14. Kinase cascades and ligand-directed signaling at the kappa opioid receptor.
Bruchas MR; Chavkin C
Psychopharmacology (Berl); 2010 Jun; 210(2):137-47. PubMed ID: 20401607
[TBL] [Abstract][Full Text] [Related]
15. Dopaminergic cellular and circuit contributions to kappa opioid receptor mediated aversion.
Margolis EB; Karkhanis AN
Neurochem Int; 2019 Oct; 129():104504. PubMed ID: 31301327
[TBL] [Abstract][Full Text] [Related]
16. Repeated swim stress induces kappa opioid-mediated activation of extracellular signal-regulated kinase 1/2.
Bruchas MR; Xu M; Chavkin C
Neuroreport; 2008 Sep; 19(14):1417-22. PubMed ID: 18766023
[TBL] [Abstract][Full Text] [Related]
17. Kappa Opioid Receptor Antagonists as Potential Therapeutics for Stress-Related Disorders.
Jacobson ML; Browne CA; Lucki I
Annu Rev Pharmacol Toxicol; 2020 Jan; 60():615-636. PubMed ID: 31914893
[TBL] [Abstract][Full Text] [Related]
18. Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats.
Knoll AT; Meloni EG; Thomas JB; Carroll FI; Carlezon WA
J Pharmacol Exp Ther; 2007 Dec; 323(3):838-45. PubMed ID: 17823306
[TBL] [Abstract][Full Text] [Related]
19. Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain.
Liu SS; Pickens S; Burma NE; Ibarra-Lecue I; Yang H; Xue L; Cook C; Hakimian JK; Severino AL; Lueptow L; Komarek K; Taylor AMW; Olmstead MC; Carroll FI; Bass CE; Andrews AM; Walwyn W; Trang T; Evans CJ; Leslie FM; Cahill CM
J Neurosci; 2019 May; 39(21):4162-4178. PubMed ID: 30862664
[TBL] [Abstract][Full Text] [Related]
20. CRF1-R activation of the dynorphin/kappa opioid system in the mouse basolateral amygdala mediates anxiety-like behavior.
Bruchas MR; Land BB; Lemos JC; Chavkin C
PLoS One; 2009 Dec; 4(12):e8528. PubMed ID: 20052275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
